124 related articles for article (PubMed ID: 25642112)
1. Combining antidepressants.
Dunner DL
Shanghai Arch Psychiatry; 2014 Dec; 26(6):363-4. PubMed ID: 25642112
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
Tundo A; de Filippis R; Proietti L
World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
[TBL] [Abstract][Full Text] [Related]
3. Medication options in the treatment of treatment-resistant depression.
Pridmore S; Turnier-Shea Y
Aust N Z J Psychiatry; 2004 Apr; 38(4):219-25. PubMed ID: 15038800
[TBL] [Abstract][Full Text] [Related]
4. Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy.
Saah T; Garlow SJ; Rapaport MH
Shanghai Arch Psychiatry; 2014 Dec; 26(6):360-2. PubMed ID: 25642111
[TBL] [Abstract][Full Text] [Related]
5. Using adjunctive treatments when first-line antidepressants fail.
Thase ME
J Clin Psychiatry; 2012 Jan; 73(1):e01. PubMed ID: 22316580
[TBL] [Abstract][Full Text] [Related]
6. Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: a naturalistic study.
Köhler S; Unger T; Hoffmann S; Steinacher B; Fydrich T; Bschor T
Pharmacopsychiatry; 2013 Mar; 46(2):69-76. PubMed ID: 23093475
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Treatments for Patients with Treatment-Resistant Depression.
Ruberto VL; Jha MK; Murrough JW
Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32512768
[TBL] [Abstract][Full Text] [Related]
8. When is antidepressant polypharmacy appropriate in the treatment of depression?
Si T; Wang P
Shanghai Arch Psychiatry; 2014 Dec; 26(6):357-9. PubMed ID: 25642110
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.
Bobo WV; Shelton RC
Expert Rev Neurother; 2010 May; 10(5):651-70. PubMed ID: 20420487
[TBL] [Abstract][Full Text] [Related]
10. Treatment response and duration of maintenance treatment with adjunctive antidepressants in bipolar depression: A retrospective chart review.
Kang SH; Kim YJ; An H; Joo YH; Kim CY
Int J Psychiatry Clin Pract; 2009; 13(2):130-7. PubMed ID: 24916732
[TBL] [Abstract][Full Text] [Related]
11. Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression.
Hassan AK; Farmer KC; Brahm NC; Neas BR
Int J Clin Pharm; 2016 Apr; 38(2):429-37. PubMed ID: 26935957
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological treatment of resistant depression].
Bertera HJ
Vertex; 2005; 16(64):460-8. PubMed ID: 16314901
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of standard depression therapy.
Marangell LB
Clin Ther; 2000; 22 Suppl A():A25-38; discussion A39-41. PubMed ID: 10815648
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapeutic strategies for patients treated for depression in UK primary care: a database analysis.
Lamy FX; Chollet J; Clay E; Brignone M; Rive B; Saragoussi D
Curr Med Res Opin; 2015 Apr; 31(4):795-807. PubMed ID: 25690488
[TBL] [Abstract][Full Text] [Related]
15. Pindolol augmentation of antidepressants: a review and rationale.
Olver JS; Cryan JF; Burrows GD; Norman TR
Aust N Z J Psychiatry; 2000 Feb; 34(1):71-9. PubMed ID: 11185947
[TBL] [Abstract][Full Text] [Related]
16. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
17. Recognition and management of depression in primary care: a focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressants.
Barkin RL; Schwer WA; Barkin SJ
Am J Ther; 2000 May; 7(3):205-26. PubMed ID: 11317169
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy.
Rogóż Z
Pharmacol Rep; 2013; 65(6):1535-44. PubMed ID: 24553002
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant efficacy and side effect burden: an updated guide for clinicians.
Kutzer T; Dick M; Scudamore T; Wiener M; Schwartz T
Drugs Context; 2020; 9():. PubMed ID: 32523610
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
